Epidermolysis bullosa dystrophica
(Redirected from Hallopeau–Siemens variant of epidermolysis bullosa)
Epidermolysis bullosa dystrophica (EBD) is a rare genetic disorder that causes the skin to become fragile and blister easily. This condition is part of a group of disorders known as epidermolysis bullosa.
Symptoms[edit | edit source]
The main symptom of EBD is the formation of painful, fluid-filled blisters on the skin. These blisters can occur anywhere on the body, but are most common on the hands and feet. Other symptoms can include:
- Nail dystrophy or loss of nails
- Thickening of the skin on the palms and soles of the feet
- Difficulty swallowing due to blistering in the esophagus
- Dental problems such as tooth decay and gum disease
- Anemia
- Growth retardation in severe cases
Causes[edit | edit source]
EBD is caused by mutations in the COL7A1 gene. This gene provides instructions for making a protein that is used to assemble type VII collagen, a major component of the anchoring fibrils that attach the epidermis (the outer layer of skin) to the underlying dermis. Mutations in the COL7A1 gene disrupt the normal formation of these fibrils, leading to the fragile skin and mucous membranes characteristic of EBD.
Diagnosis[edit | edit source]
Diagnosis of EBD is usually based on the characteristic symptoms and confirmed by genetic testing. Skin biopsy may also be performed to examine the skin under a microscope and to test for the presence of type VII collagen.
Treatment[edit | edit source]
There is currently no cure for EBD. Treatment is aimed at managing the symptoms and preventing complications. This can include:
- Wound care to prevent infection
- Pain management
- Nutritional support to prevent malnutrition
- Physical therapy to maintain mobility and prevent contractures
- Dental care to prevent tooth decay and gum disease
Prognosis[edit | edit source]
The prognosis for individuals with EBD varies depending on the severity of the condition. Some individuals may have a normal lifespan with mild symptoms, while others may experience severe complications and have a shortened lifespan.
See also[edit | edit source]
Epidermolysis bullosa dystrophica Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD